Combigene
Clarification regarding the management's role during the restructuring period
MARKN.
CombiGene AB (publ) (“CombiGene”, the “Company”) would like to clarify this morning's memo by stating that the current CEO and management will remain in their roles during the notice period. During this time, the board is working to ensure a management structure that is adapted to the company's future needs.
Datum | 2025-01-09, kl 15:50 |
Källa | MFN |

Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet